OTC - ACTIVE INGREDIENT SECTION
Argentum nit 15X (HPUS)
Brayta Carb. 15X (HPUS)
Dulcamara 15X (HPUS)
Gelsemium 15X (HPUS)
Kali Brom 15X (HPUS)
Nat Mur 15X (HPUS)
Causticum 15X (HPUS)
Argentum nit 15X (HPUS)
Brayta Carb. 15X (HPUS)
Dulcamara 15X (HPUS)
Gelsemium 15X (HPUS)
Kali Brom 15X (HPUS)
Nat Mur 15X (HPUS)
Causticum 15X (HPUS)
Indications:
For detail please read the enclosed
package (Product information leaflet).
Indications:
For detail please read the enclosed
package (Product information leaflet).
Dosage:
10-15 drops, 3-4 times a day in
some water.
Precautions/storage:
Keep away from children and store
at cool and dry place.
Precautions/storage:
Keep away from children and store
at cool and dry place.
Alcohol
Package 1
Package 2
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 85816-2068 | 85816-2068-1, 85816-2068-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CAUSTICUM | DD5FO1WKFU | ACTIB |
| POTASSIUM BROMIDE | OSD78555ZM | ACTIB |
| BARIUM CARBONATE | 6P669D8HQ8 | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| SOLANUM DULCAMARA TOP | KPS1B1162N | ACTIB |
| SILVER NITRATE | 95IT3W8JZE | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| GELSEMIUM SEMPERVIRENS ROOT | 639KR60Q1Q | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 1 | 2026-06-11 | daily-update | 2026-06-16 05:10:06 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BM BM68 DROPS | ARGENTUM NIT, BARYTA CARB., DULCAMARA, GELSEMIUM, KALI BROM, NAT MUR, CAUSTICUM | BM Private Limited | 53f9c99a-0f20-0358-e063-6394a90af4e0 | 2026-06-15 | Warnings | 85816-2068-2 85816-2068-1 85816-2068 85816206801 85816206802 5447f849-ae7a-b2b8-e063-6394a90af158 53f9c99a-0f20-0358-e063-6394a90af4e0 |
Adverse event summaries are temporarily unavailable. Other product information remains available.